Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
CHOP-Style Chemotherapy for Canine Lymphoma: Protocol Discussion Profile
CHOP is a family of veterinary lymphoma protocols built around cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone. Exact sequence, dose and duration vary by oncology service and patient.
Read more
Named profile Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma TherapyRepresentative category illustration – no product packaging is shown.Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma Therapy
Rabacfosadine is a canine lymphoma drug whose current official label, patient selection, cumulative risks, and availability must be verified before use.
Read moreCisplatin in Dogs: Species-Specific and Kidney-Safety Boundary
Cisplatin is a platinum chemotherapy used only in carefully selected veterinary settings; it has major kidney, gastrointestinal, infusion, and species-specific hazards.
Read moreNamed profile Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy ProfileRepresentative category illustration – no product packaging is shown.Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy Profile
streptozotocin is covered as nitrosourea antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile 5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity WarningRepresentative category illustration – no product packaging is shown.5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity Warning
5-fluorouracil (5-FU) is covered as fluoropyrimidine antimetabolites; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety ProfileRepresentative category illustration – no product packaging is shown.Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety Profile
vinorelbine is covered as vinca alkaloid antimitotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.Mitotane in Canine Adrenal Disease and Adrenocortical Tumours
mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile
paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile
docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols
MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Melphalan and Prednisone or Prednisolone for Canine Multiple MyelomaRepresentative category illustration – no product packaging is shown.Melphalan and Prednisone or Prednisolone for Canine Multiple Myeloma
melphalan with prednisone or prednisolone is covered as oral alkylator-based protocol for canine multiple myeloma, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Vinblastine and Prednisone or Prednisolone for Canine Mast Cell TumoursRepresentative category illustration – no product packaging is shown.Vinblastine and Prednisone or Prednisolone for Canine Mast Cell Tumours
vinblastine with prednisone or prednisolone is covered as combination chemotherapy for selected canine mast-cell tumours, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more